Fulgent Genetics, Inc.FLGTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-19.25M
↓ 123% below average
Average (9y)
$83.35M
Historical baseline
Range
High:$514.73M
Low:$-19.25M
CAGR
+22.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-19.25M | -501.5% |
| 2023 | $4.80M | -98.0% |
| 2022 | $234.75M | -54.4% |
| 2021 | $514.73M | +394.4% |
| 2020 | $104.12M | +2301.8% |
| 2019 | $4.33M | +223.6% |
| 2018 | $-3.51M | +12.9% |
| 2017 | $-4.03M | -752.4% |
| 2016 | $617000.00 | +120.1% |
| 2015 | $-3.07M | - |